Vaccines impact factor, indexing, ranking (2024)


vaccines

Aim and Scope

The Vaccines is a research journal that publishes research related to Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics. This journal is published by the Multidisciplinary Digital Publishing Institute (MDPI). The ISSN of this journal is 2076393X. Based on the Scopus data, the SCImago Journal Rank (SJR) of vaccines is 1.655.

Also, please check the following important details about vaccines: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.

According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.

Vaccines Ranking

Impact Factor: 4.961
Total Citations: 11012
SJR (SCImago Journal Rank): 1.655
Quartile: Q1

The Impact Factor of Vaccines is 4.961.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.

The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.


Important Metrics

Journal Title: Vaccines
Publisher: Multidisciplinary Digital Publishing Institute (MDPI)
ISSN: 2076393X
Type: journal
Journal Scope: Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics
Country: Switzerland
H-Index: 67
SJR: 1.655
Quartile: Drug Discovery (Q1); Immunology (Q1); Infectious Diseases (Q1); Pharmacology (Q1); Pharmacology (medical) (Q1)

vaccines Indexing

The vaccines is indexed in:

An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.

The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).


Vaccines Impact Factor 2024

The latest impact factor of vaccines is 4.961.

The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.

Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.


Vaccines Quartile

The latest Quartile of vaccines is Q1.

Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.


Publication fee

According to journal website, the publication fee of vaccines is around 2200 CHF.

The vaccines has also Journal waiver policy (for developing countries, authors etc).

An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.


Journal Publication Time

The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the vaccines publishes research articles in 6 weeks on an average.



Call for Papers

Visit to the official website of the journal/ conference to check the details about call for papers.

How to publish in Vaccines?

If your research is related to Immunology and Microbiology; Medicine; Pharmacology, Toxicology and Pharmaceutics, then visit the official website of vaccines and send your manuscript.

Tips for publishing in Vaccines:

Acceptance Rate

Acceptance rate is the ratio of the number of articles submitted to the number of articles published. Researchers can check the acceptance rate on the journal website. Alternatively, they can contact the editor of the journal.

Final Summary

  • The impact factor of vaccines is 4.961.
  • The vaccines is a reputed research journal.
  • It is published by Multidisciplinary Digital Publishing Institute (MDPI).
  • The journal is indexed in UGC CARE, Scopus, SCIE, DOAJ, PubMed.
  • It is an open access journal.
  • The (SJR) SCImago Journal Rank is 1.655.
  • The publication time (Average number of weeks between article submission and publication) of the journal is 6 weeks.
  • The Publication fee (APC) of vaccines 2200 CHF.

Sources: http://www.mdpi.com/journal/vaccines







SIMILIAR JOURNALS


JOURNAL OF ANTIBIOTICS

ISSN: 0021-8820
Publisher: SPRINGERNATURE

IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY

ISSN: 0892-3973
Publisher: TAYLOR & FRANCIS LTD

REGULATORY TOXICOLOGY AND PHARMACOLOGY

ISSN: 0273-2300
Publisher: ACADEMIC PRESS INC ELSEVIER SCIENCE

FOOD AND AGRICULTURAL IMMUNOLOGY

ISSN: 0954-0105
Publisher: TAYLOR & FRANCIS LTD

INFLAMMOPHARMACOLOGY

ISSN: 0925-4692
Publisher: SPRINGER BASEL AG

INNATE IMMUNITY

ISSN: 1753-4259
Publisher: SAGE PUBLICATIONS LTD

BIOMARKERS

ISSN: 1354-750X
Publisher: TAYLOR & FRANCIS LTD

MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS

ISSN: 1386-1964
Publisher: ELSEVIER

MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS

ISSN: 1383-5718
Publisher: ELSEVIER

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH

ISSN: 1383-5742
Publisher: ELSEVIER

TOP RESEARCH JOURNALS

Credit and Source: Scopus, Clarivate, UGC CARE.